Medical Weight Loss Treatment for Nebraska Residents
Medically Supervised Weight Loss, Delivered Online
Our providers are licensed by the Nebraska Board of Medicine and Surgery for comprehensive statewide telehealth services.
Whether you're in Omaha, Lincoln, or anywhere across Nebraska — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Nebraska
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Nebraska's strength is in its people—hardworking farmers, innovative entrepreneurs in Omaha, and tight-knit communities across the plains. OmniRx Health serves this Cornhusker spirit by bringing healthcare to where you are. Whether you're in downtown Omaha, cheering for the Huskers in Lincoln, or running a cattle operation in the Sandhills, our telehealth platform connects you with expert care. No more driving hours across the state when you can consult a board-certified provider from your living room.
Available Treatments in Nebraska
Our board-certified providers in Nebraska can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Nebraska
State Licensing
Our providers are licensed by the Nebraska Board of Medicine and Surgery for comprehensive statewide telehealth services.
Telehealth Law
Nebraska's telehealth regulations support virtual care delivery while ensuring patient safety standards are maintained.
Pharmacy Access
Nebraska pharmacies in Omaha, Lincoln, and throughout rural communities ensure prescription access with reliable home delivery.
Insurance Notes
Nebraska insurers cover telehealth services, with ongoing efforts to expand access and ensure fair reimbursement for virtual care.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Nebraska
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.